In an unusual (if not unprecedented) move, the Solicitor General of the United States wrote a letter to the Federal Circuit asking that oral argument in Association for Molecular Pathology v. Myriad Genetics be scheduled for April 4, 2011. The Solicitor General (Neal Katyal) noted that “the United States will file an unopposed motion to participate in … Continue reading this entry
Tags: ACLU, Association For Molecular Pathology, BRCA, Breast Cancer, Department of Justice, DNA, DOJ, Eligibility, Gene, Isolated, Myriad, Nature, Pure, USPTO
In a move that surprised many in the U.S. patent community, the Department of Justice filed a brief in the Federal Circuit appeal of Association for Molecular Pathology v. USPTO, arguing against the patentability of isolated genomic DNA sequences. This brief may raise the stakes in the appeal, and certainly shines a brighter spotlight on … Continue reading this entry
Tags: ACLU, Association For Molecular Pathology, BRCA, Breast Cancer, Department of Justice, DNA, DOJ, Eligibility, Gene, Isolated, Myriad, Nature, Pure, USPTO
Posted in 101; Myriad; Personalized Medicine